Xtl Biopharmaceuticals (XTLB) Revenue (2011 - 2024)

Xtl Biopharmaceuticals (XTLB) reported Revenue of $289000.0 for Q4 2024, up 4716.67% sequentially from $6000.0 in Q1 2022.

Xtl Biopharmaceuticals (XTLB) Revenue (2011 - 2024) Analysis & Trends

Xtl Biopharmaceuticals (XTLB) has 11 years of Revenue data on file, last reported at $289000.0 in Q4 2024.

  • For the quarter ending Q4 2024, Revenue changed N/A year-over-year to $289000.0; the trailing twelve-month figure through Dec 2024 stood at $300000.0 (changed N/A YoY), and the FY2025 full-year result was -$549000.0, down 221.73% from the prior year.
  • Revenue climbed to $289000.0 in Q4 2024, from $6000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $289000.0 in Q4 2024 to a low of -$7000.0 in Q1 2021.
  • A 4-year average of $61400.0 and a median of $7000.0 in 2020 frame the typical range for Revenue.
  • Across the five-year window, Revenue slumped 200.0% in 2021 and surged 185.71% in 2022, its largest moves.
  • Tracing XTLB's Revenue over 4 years: stood at $12000.0 in 2020, then slumped by 158.33% to -$7000.0 in 2021, then surged by 185.71% to $6000.0 in 2022, then surged by 4716.67% to $289000.0 in 2024.
  • Business Quant data shows XTLB's Revenue at $289000.0 in Q4 2024, $6000.0 in Q1 2022, and -$7000.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.51 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 1.30 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Xtl Biopharmaceuticals 2.56 Bn 2.56 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 289,000.00
Mar 31, 2022 6,000.00
Mar 31, 2021 -7,000.00
Dec 31, 2020 12,000.00
Mar 31, 2020 7,000.00
Sep 30, 2018 1.03 Mn
Jun 30, 2018 34,000.00
Mar 31, 2018 875,000.00
Sep 30, 2017 -1.59 Mn
Jun 30, 2017 1.39 Mn
Mar 31, 2017 977,000.00
Sep 30, 2016 286,000.00
Jun 30, 2016 477,000.00
Mar 31, 2016 577,000.00
Sep 30, 2014 287,000.00
Jun 30, 2014 380,000.00
Mar 31, 2014 587,000.00
Dec 31, 2013 711,000.00
Sep 30, 2013 473,000.00
Jun 30, 2013 512,000.00